ORA, Inc.
ORA, Inc.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-10 | NCT05984927 | |
| A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye | dry eye syndrome, eye disorder, lacrimal apparatus disorder | Not yet recruiting | Phase 2 | 2025-07-16 | NCT07068958 | |
| Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD | Geographic Atrophy, age-related macular degeneration, cataract, eye disorder, lens disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Not applicable | 2024-12-03 | NCT05438732 | |
| Study of OT-101 in Treating Myopia | Myopia, Progressive, degenerative myopia, eye disorder, myopia, refractive error | Active, not recruiting | Phase 3 | 2023-08-08 | NCT04770610 |